Wilkie H, Timilshina M, Rahmayanti S, Das M, Pelovitz T, Geha R
Clin Immunol. 2023; 254:109681.
PMID: 37385324
PMC: 10529992.
DOI: 10.1016/j.clim.2023.109681.
Li S, Guo Y, Tian J, Zhang H, Li R, Gong P
Cancers (Basel). 2023; 15(10).
PMID: 37345054
PMC: 10216167.
DOI: 10.3390/cancers15102717.
Castiello M, Ferrari S, Villa A
Semin Immunol. 2023; 66:101731.
PMID: 36863140
PMC: 10109147.
DOI: 10.1016/j.smim.2023.101731.
Yuan B, Zhou X, Suzuki K, Ramos-Mandujano G, Wang M, Tehseen M
Nat Commun. 2022; 13(1):3646.
PMID: 35752626
PMC: 9233711.
DOI: 10.1038/s41467-022-31220-8.
Moreiras H, Bento-Lopes L, Neto M, Escrevente C, Cabaco L, Hall M
Traffic. 2022; 23(6):331-345.
PMID: 35426185
PMC: 9543991.
DOI: 10.1111/tra.12843.
Targeting the actin nucleation promoting factor WASp provides a therapeutic approach for hematopoietic malignancies.
Biber G, Ben-Shmuel A, Noy E, Joseph N, Puthenveetil A, Reiss N
Nat Commun. 2021; 12(1):5581.
PMID: 34552085
PMC: 8458504.
DOI: 10.1038/s41467-021-25842-7.
Hematopoietic Stem Cell Therapy for Wiskott-Aldrich Syndrome: Improved Outcome and Quality of Life.
Mallhi K, Petrovic A, Ochs H
J Blood Med. 2021; 12:435-447.
PMID: 34149291
PMC: 8206065.
DOI: 10.2147/JBM.S232650.
Wiskott Aldrich Syndrome: A Multi-Institutional Experience From India.
Suri D, Rikhi R, Jindal A, Rawat A, Sudhakar M, Vignesh P
Front Immunol. 2021; 12:627651.
PMID: 33936041
PMC: 8086834.
DOI: 10.3389/fimmu.2021.627651.
Disease Presentation, Treatment Options, and Outcomes for Myeloid Immunodeficiencies.
Kang E
Curr Allergy Asthma Rep. 2021; 21(3):14.
PMID: 33666780
PMC: 8162003.
DOI: 10.1007/s11882-020-00984-8.
RHO GTPases: from new partners to complex immune syndromes.
El Masri R, Delon J
Nat Rev Immunol. 2021; 21(8):499-513.
PMID: 33547421
DOI: 10.1038/s41577-021-00500-7.
Higher Incidence of B Cell Malignancies in Primary Immunodeficiencies: A Combination of Intrinsic Genomic Instability and Exocytosis Defects at the Immunological Synapse.
Mastio J, Saeed M, Wurzer H, Krecke M, Westerberg L, Thomas C
Front Immunol. 2020; 11:581119.
PMID: 33240268
PMC: 7680899.
DOI: 10.3389/fimmu.2020.581119.
Physical Constraints and Forces Involved in Phagocytosis.
Jaumouille V, Waterman C
Front Immunol. 2020; 11:1097.
PMID: 32595635
PMC: 7304309.
DOI: 10.3389/fimmu.2020.01097.
Endocytosis and the internalization of pathogenic organisms: focus on phosphoinositides.
Walpole G, Grinstein S
F1000Res. 2020; 9.
PMID: 32494357
PMC: 7233180.
DOI: 10.12688/f1000research.22393.1.
COMMD10-Guided Phagolysosomal Maturation Promotes Clearance of Staphylococcus aureus in Macrophages.
Shlomo S, Mouhadeb O, Cohen K, Varol C, Gluck N
iScience. 2019; 14:147-163.
PMID: 30959277
PMC: 6453835.
DOI: 10.1016/j.isci.2019.03.024.
Beyond being innervated: the epidermis actively shapes sensory dendritic patterning.
Yang W, Chien C
Open Biol. 2019; 9(3):180257.
PMID: 30914004
PMC: 6451362.
DOI: 10.1098/rsob.180257.
Interfacial actin protrusions mechanically enhance killing by cytotoxic T cells.
Tamzalit F, Wang M, Jin W, Tello-Lafoz M, Boyko V, Heddleston J
Sci Immunol. 2019; 4(33).
PMID: 30902904
PMC: 6746172.
DOI: 10.1126/sciimmunol.aav5445.
A novel splice site mutation in WAS gene in patient with Wiskott-Aldrich syndrome and chronic colitis: a case report.
Esmaeilzadeh H, Bordbar M, Dastsooz H, Silawi M, Fard M, Adib A
BMC Med Genet. 2018; 19(1):123.
PMID: 30029636
PMC: 6054734.
DOI: 10.1186/s12881-018-0647-0.
Clinical Manifestations and Pathophysiological Mechanisms of the Wiskott-Aldrich Syndrome.
Candotti F
J Clin Immunol. 2017; 38(1):13-27.
PMID: 29086100
DOI: 10.1007/s10875-017-0453-z.
Wiskott-Aldrich syndrome protein: Emerging mechanisms in immunity.
Rivers E, Thrasher A
Eur J Immunol. 2017; 47(11):1857-1866.
PMID: 28805251
PMC: 7612068.
DOI: 10.1002/eji.201646715.
Yersinia effector YopO uses actin as bait to phosphorylate proteins that regulate actin polymerization.
Lee W, Grimes J, Robinson R
Nat Struct Mol Biol. 2015; 22(3):248-55.
PMID: 25664724
PMC: 4745138.
DOI: 10.1038/nsmb.2964.